Verrica appoints David Zawitz as COO effective Dec 9; grants 950,000 option shares

Verrica Pharmaceuticals Inc.

David Zawitz appointed Chief Operating Officer and principal operating officer, effective Dec 9, 2024.
Base salary of $250,000/year; target annual bonus of 40% of base salary.
Option grant for 950,000 shares at closing price on grant date, vesting over 4 years with accelerated vesting on change-in-control termination.
2024 Inducement Plan shares increased from 2,000,000 to 4,500,000 to accommodate the grant.
Zawitz to continue consulting for PBM Capital with Board approval for increased time.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.